Shanxi C&Y Pharmaceutical Group Co Ltd (300254) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.092x

Based on the latest financial reports, Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a cash flow conversion efficiency ratio of 0.092x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.93 Million ≈ $7.75 Million USD) by net assets (CN¥577.09 Million ≈ $84.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Shanxi C&Y Pharmaceutical Group Co Ltd to measure how much of total assets are equity-financed.

Shanxi C&Y Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Shanxi C&Y Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Shanxi C&Y Pharmaceutical Group Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

Shanxi C&Y Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanxi C&Y Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
NEWRON PHARMACEUT. EO-20
F:NP5
N/A
Funko Inc
NASDAQ:FNKO
0.060x
Schweizerische Nationalbank
SW:SNBN
0.000x
National CineMedia Inc
NASDAQ:NCMI
0.001x
Australian Finance Group Ltd
AU:AFG
0.102x
Fujian Jinsen Forestry Co Ltd
SHE:002679
-0.009x
E Split Corp Class A
TO:ENS
0.100x
Cantor Equity Partners II, Inc.
NASDAQ:CEPT
N/A

Annual Cash Flow Conversion Efficiency for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Shanxi C&Y Pharmaceutical Group Co Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥594.33 Million
≈ $86.97 Million
CN¥96.77 Million
≈ $14.16 Million
0.163x +37.29%
2024-12-31 CN¥598.18 Million
≈ $87.53 Million
CN¥70.94 Million
≈ $10.38 Million
0.119x +144.13%
2023-12-31 CN¥778.43 Million
≈ $113.91 Million
CN¥37.81 Million
≈ $5.53 Million
0.049x -52.66%
2022-12-31 CN¥729.68 Million
≈ $106.78 Million
CN¥74.88 Million
≈ $10.96 Million
0.103x -21.17%
2021-12-31 CN¥744.58 Million
≈ $108.96 Million
CN¥96.92 Million
≈ $14.18 Million
0.130x +644.07%
2020-12-31 CN¥872.61 Million
≈ $127.69 Million
CN¥-20.88 Million
≈ $-3.05 Million
-0.024x -132.04%
2019-12-31 CN¥932.60 Million
≈ $136.47 Million
CN¥69.63 Million
≈ $10.19 Million
0.075x +80.88%
2018-12-31 CN¥931.24 Million
≈ $136.27 Million
CN¥38.44 Million
≈ $5.63 Million
0.041x -0.04%
2017-12-31 CN¥971.17 Million
≈ $142.11 Million
CN¥40.10 Million
≈ $5.87 Million
0.041x -5.33%
2016-12-31 CN¥954.85 Million
≈ $139.72 Million
CN¥41.65 Million
≈ $6.09 Million
0.044x +146.44%
2015-12-31 CN¥872.50 Million
≈ $127.67 Million
CN¥15.44 Million
≈ $2.26 Million
0.018x -82.27%
2014-12-31 CN¥823.16 Million
≈ $120.45 Million
CN¥82.19 Million
≈ $12.03 Million
0.100x -4.94%
2013-12-31 CN¥767.16 Million
≈ $112.26 Million
CN¥80.58 Million
≈ $11.79 Million
0.105x +95.14%
2012-12-31 CN¥651.17 Million
≈ $95.29 Million
CN¥35.05 Million
≈ $5.13 Million
0.054x +558.60%
2011-12-31 CN¥581.17 Million
≈ $85.04 Million
CN¥4.75 Million
≈ $695.08K
0.008x -97.65%
2010-12-31 CN¥149.59 Million
≈ $21.89 Million
CN¥52.03 Million
≈ $7.61 Million
0.348x -61.24%
2009-12-31 CN¥117.60 Million
≈ $17.21 Million
CN¥105.55 Million
≈ $15.45 Million
0.898x +344.54%
2008-12-31 CN¥106.70 Million
≈ $15.61 Million
CN¥-39.16 Million
≈ $-5.73 Million
-0.367x --

About Shanxi C&Y Pharmaceutical Group Co Ltd

SHE:300254 China Drug Manufacturers - Specialty & Generic
Market Cap
$302.75 Million
CN¥2.07 Billion CNY
Market Cap Rank
#14717 Global
#4350 in China
Share Price
CN¥8.08
Change (1 day)
+3.19%
52-Week Range
CN¥7.27 - CN¥14.68
All Time High
CN¥31.09
About

ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, respiratory drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, anti-depressants, medicines, pharmaceutical raw materials, and intermediates, comme… Read more